Gene · 9113
Papers3,081
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 3,081
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Analysis of Alternative mRNA Splicing in Vemurafenib-Resistant Melanoma Cells. | Biomolecules | 2022 | 35883549 | PubTator, text mining | PubMed |
| Dual Function of Par3 in Tumorigenesis. | Front Oncol | 2022 | 35875120 | PubTator, text mining | PubMed |
| Development of an improved inhibitor of Lats kinases to promote regeneration of mammalian organs. | Proc Natl Acad Sci U S A | 2022 | 35867764 | PubTator, text mining | PubMed |
| Smoke-induced SAV1 Gene Promoter Hypermethylation Disrupts YAP Negative Feedback and Promotes Malignant Progression of Non-small Cell Lung Cancer. | Int J Biol Sci | 2022 | 35864957 | PubTator, text mining | PubMed |
| Sensitivity to Vaccines, Therapeutic Antibodies, and Viral Entry Inhibitors and Advances To Counter the SARS-CoV-2 Omicron Variant. | Clin Microbiol Rev | 2022 | 35862736 | PubTator, text mining | PubMed |
| ADSCs Promote Tenocyte Proliferation by Reducing the Methylation Level of lncRNA Morf4l1 in Tendon Injury. | Front Chem | 2022 | 35860629 | PubTator, text mining | PubMed |
| C12orf59 Promotes Esophageal Squamous Cell Carcinoma Progression via YAP-Mediated Epithelial-Mesenchymal Transition. | Front Oncol | 2022 | 35860553 | PubTator, text mining | PubMed |
| LATS kinases and SLUG regulate the transition to advanced stage in aggressive oral cancer cells. | Sci Rep | 2022 | 35859006 | PubTator, text mining | PubMed |
| N-glycosylation of GDF15 abolishes its inhibitory effect on EGFR in AR inhibitor-resistant prostate cancer cells. | Cell Death Dis | 2022 | 35853851 | PubTator, text mining | PubMed |
| Targeting Ferroptosis Pathway to Combat Therapy Resistance and Metastasis of Cancer. | Front Pharmacol | 2022 | 35847022 | PubTator, text mining | PubMed |
| Vascular Endothelial Growth Factor Receptor-1 Modulates Hypoxia-Mediated Endothelial Senescence and Cellular Membrane Stiffness via YAP-1 Pathways. | Front Cell Dev Biol | 2022 | 35846360 | PubTator, text mining | PubMed |
| Association of alkaptonuria and low dose nitisinone therapy with cataract formation in a large cohort of patients. | JIMD Rep | 2022 | 35822094 | PubTator, text mining | PubMed |
| Sestrin2 attenuates renal damage by regulating Hippo pathway in diabetic nephropathy. | Cell Tissue Res | 2022 | 35821438 | PubTator, text mining | PubMed |
| DUB1 suppresses Hippo signaling by modulating TAZ protein expression in gastric cancer. | J Exp Clin Cancer Res | 2022 | 35820928 | PubTator, text mining | PubMed |
| Targeted Proteomic Approaches for Proteome-Wide Characterizations of the AMP-Binding Capacities of Kinases. | J Proteome Res | 2022 | 35820187 | PubTator, text mining | PubMed |
| ITCH facilitates proteasomal degradation of TXNIP in hypoxia- induced lung cancer cells. | Thorac Cancer | 2022 | 35811256 | PubTator, text mining | PubMed |
| Gankyrin modulated non-small cell lung cancer progression via glycolysis metabolism in a YAP1-dependent manner. | Cell Death Discov | 2022 | 35810157 | PubTator, text mining | PubMed |
| PFKFB3 regulates cancer stemness through the hippo pathway in small cell lung carcinoma. | Oncogene | 2022 | 35804016 | PubTator, text mining | PubMed |
| Liquid-liquid phase separation in tumor biology. | Signal Transduct Target Ther | 2022 | 35803926 | PubTator, text mining | PubMed |
| SUFU suppresses ferroptosis sensitivity in breast cancer cells via Hippo/YAP pathway. | iScience | 2022 | 35800779 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9113/papers?page=38